Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nice
Clinical trial register · France

Clinical Trials in Nice, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 2821 Lyon 1392 Bordeaux 1389 Marseille 1285 Lille 1282
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Centre Hospitalier Universitaire de Nice194 AbbVie32 Merck Sharp & Dohme LLC21 Novartis Pharmaceuticals20 Centre Antoine Lacassagne19
Site location
Paris2821 Lyon1392 Bordeaux1389 Marseille1285 Lille1282
All 804 locations
Target enrolment
to

Trials with a site in Nice

768 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
400
Nice
2030-09
Not yet open
Centre Antoine Lacassagne
Not applicable
1,222
Marseille, Nice
2027-01-31
Not yet open
Dexmedetomidine for Invasive Ventilation In the NEOnate
NCT07493785Invasive Ventilation, Infant Pain, Infant Discomfort, Infant Neurodevelopment
DrugDexmedetomidine
Centre Hospitalier Intercommunal Creteil
Phase 2/3
246
Brest, Créteil, Grenoble, Lille, Limoges, Nantes, Nice, Paris
2027-01-01
Not yet open
CGBio Inc.
Not applicable
100
Cannes, Nice, Paris
2027-01
Not yet open
University Hospital, Lille
Observational
400
Béziers, Bordeaux, Brest, Caen, Lille, Lyon, Marseille, Nice
2027-01
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Grenoble, Angers, Nantes, Marseille, Bobigny, Brest, Dijon, Nice
2026-12-16
Not yet open
Functional Outcomes in Older Adults With Fragility Fractures of the Pelvis: The FFP-France Study
NCT07871084Fragility Fractures of the Pelvis (FFP), Osteoporotic Fractures
Centre Hospitalier Universitaire de Nice
Observational
200
Nice
2026-12-01
Not yet open
Centre Hospitalier Universitaire de Nice
Observational
500
Nice
2026-12-01
Not yet open
AbbVie
Phase 3
520
Nice, Tours, Vandœuvre-lès-Nancy, Nantes, Avignon
2026-11-30
Not yet open
PharmaMar
Phase 1/2
231
Bordeaux, Lyon, Nice
2026-11-12
Not yet open
Assistance Publique - Hôpitaux de Paris
Phase 3
184
Amiens, Angers, Bobigny, Clermont-Ferrand, Colombes, Créteil, Le Kremlin-Bicêtre, Nice
2026-11-03
Not yet open
Centre Hospitalier Universitaire de Nice
Phase 2
20
Nice
2026-11-01
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
120
Nice
2026-11-01
Not yet open
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
158
Clermont-Ferrand, Lyon, Nice, Reims, Villejuif
2026-11
Not yet open
Centre Hospitalier Universitaire de Nice
Observational
100
Nice
2026-11
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
12
Nice
2026-10-31
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
100
Nice
2026-10-05
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
15
Nice
2026-10-01
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 2
56
Nice, Paris, Reims, Rouen, Tours
2026-10-01
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
25
Nice
2026-10
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
50
Nice
2026-10
Not yet open
Centre Antoine Lacassagne
Not applicable
50
Nice
2026-10
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
65
Nice
2026-09-28
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 2/3
170
Nice
2026-09-23
Recruiting
Hospices Civils de Lyon
Not applicable
316
Amiens, Besançon, Bron, La Tronche, Lyon, Marseille, Nice, Saint-Priest-en-Jarez
2026-09-21
Not yet open
UNICANCER
Phase 2
51
Bordeaux, Lyon, Marseille, Nice, Paris, Rennes, Saint-Herblain, Toulouse
2026-09-18
Recruiting
Boehringer Ingelheim
Phase 3
466
Angers, Bobigny, Bron, Caen, La Tronche, Lille, Marseille, Nice
2026-09-17
Recruiting
INNOVATIVE BENEFITS OF A 4D VIRTUAL SIMULATOR
NCT07499869Temporomandibular Disorders (TMD)
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice
2026-09-17
Recruiting
Daiichi Sankyo
Phase 1/2
220
Caen, Dijon, Lille, Lyon, Marseille, Montpellier, Nice, Nîmes
2026-09-17
Recruiting
Centre Antoine Lacassagne
Not applicable
98
Nice
2026-09-15
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice
2026-09-11
Recruiting
Bristol-Myers Squibb
Phase 2
160
Nice, Montpellier, Villejuif, Grenoble, Marseille, Paris, Saint-Herblain
2026-09-10
Recruiting
Takeda
Phase 3
324
Nice, Pierre-Bénite, Strasbourg, Marseille, Brest, Pessac, Lille, Paris
2026-09-10
Recruiting
Incyte Corporation
Phase 3
426
Amiens, Bordeaux, Brest, Créteil, Le Kremlin-Bicêtre, Nice, Paris, Poitiers
2026-09-08
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
60
Nice
2026-09-02
Not yet open
Centre Hospitalier Universitaire de Nice
Phase 2/3
5
Nice
2026-09-01
Not yet open
Study Evaluating the Predictive Value of the Terminal Latency Index (TLI) for Treatment Response in Patients With Anti-MAG Neuropathy
NCT07794137Anti-MAG Neuropathy, Peripheral Nervous System Disease, Anti-Myelin-Associated Glycoprotein Antibodie
Centre Hospitalier Universitaire de Nice
Observational
100
Nice
2026-09-01
Not yet open
Centre Hospitalier Universitaire de Nice
Observational
180
Nice
2026-09-01
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
10
Nice
2026-09
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
45
Nice
2026-09
Not yet open
Outcome of Patients With Severe Mental Illness in the Intensive Care Unit
NCT07705802Severe Mental Illness, Severe Mental Disorder
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Observational
2,000
Nice, La Rochelle, Quincy-sous-Sénart, Boulogne-Billancourt, Rennes, Blois, Cahors, Vannes
2026-09
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
600
Nice
2026-09
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
4,500
Nice
2026-09
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
10
Nice
2026-09
Recruiting
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07845487Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis
DrugPALI-2108
Palisade Bio
Phase 2
204
Amiens, Clermont-Ferrand, Neuilly-sur-Seine, Nice, Saint-Priest-en-Jarez
2026-08-28
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 4
34
Nice
2026-08-25
Recruiting
UNICANCER
Phase 2
275
Bordeaux, Boulogne-Billancourt, Nice, Villejuif
2026-08-21
Not yet open
University Hospital, Limoges
Not applicable
88
Boulogne-Billancourt, Limoges, Nice
2026-08-01
Not yet open
Intravenous Lidocaine for Hepatectomy
NCT07590830Hepatectomy
Rennes University Hospital
Phase 4
312
Clermont-Ferrand, La Roche-sur-Yon, Le Coudray, Lille, Lyon, Nice, Paris, Rennes
2026-08-01
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
10
Nice
2026-07-30
Not yet open
Centre Hospitalier Universitaire de Nice
Observational
150
Nice, Paris
2026-07-30
Recruiting
Medical University Innsbruck
Phase 2
48
Nice, Paris
2026-07-13
Recruiting
LARKSPUR BIOSCIENCES, INC.
Phase 1/2
120
Nice, Strasbourg
2026-07-07
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
15
Nice, Paris
2026-07-01
Not yet open
Link Between ASCorbemia Level and Osteoporosis
NCT07660484Osteoporosis, Vitamin C Deficiency, Vertebral Fractures
Centre Hospitalier Universitaire de Nice
Not applicable
40
Nice
2026-07-01
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice
2026-07
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
75
Antibes, Cannes, Grasse, Nice
2026-07
Recruiting
AbbVie
Phase 2/3
660
Nice, Marseille, Pessac, Angers, Amiens, Paris
2026-06-30
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
110
Nice
2026-06-18
Recruiting
Rhythm Diagnostic Systems
Not applicable
490
Nice, Saint-Etienne, Rennes, Besançon, Reims, Bourgoin, Rouen, Amiens
2026-06-16
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
50
Nice, Angers, Boulogne-sur-Mer, Créteil, Garches, Grenoble, Lille, Limoges
2026-06-15
Recruiting
Pharming Technologies B.V.
Phase 2
140
Angers, Bordeaux, Lille, Nantes, Nice, Strasbourg
2026-06-12
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Angers, Brest, Bron, Montpellier, Nice, Paris, Rennes, Tours
2026-06-11
Recruiting
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
NCT07504458Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia With PML-RARA, Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
DrugsArsenic Trioxide·ATRA
Quetzal Therapeutics
Phase 3
150
Bordeaux, La Tronche, Nancy, Nice, Paris, Saint-Priest-en-Jarez, Strasbourg
2026-06-08
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
4
Nice, Bron, Montpellier
2026-06-01
Not yet open
Tdose Binding and Tocilizumab
NCT07582185Rheumatoid Arthritis
Centre Hospitalier Universitaire de Nice
Phase 4
122
Nice
2026-06-01
Recruiting
Inflammatory Dynamics of Innate Immune Cells
NCT07633327Peritoneal Lavage
Centre Hospitalier Universitaire de Nice
Observational
200
Nice
2026-06-01
Recruiting
LycoRed Ltd.
Not applicable
60
Nice
2026-06-01
Not yet open
Fondation Lenval
Not applicable
100
Nice
2026-06
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Amiens, Besançon, Clichy, Le Kremlin-Bicêtre, Lille, Montpellier, Nantes, Nice
2026-05-23
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Besançon, Clichy, Le Kremlin-Bicêtre, Lille, Montpellier, Nantes, Nice, Pessac
2026-05-22
Recruiting
Takeda
Phase 3
300
La Tronche, Poitiers, Villejuif, Nice, Paris
2026-05-21
Recruiting
Hoffmann-La Roche
Phase 2/3
650
Grenoble, Lyon, Nice, Rennes, Toulouse
2026-05-21
Recruiting
Mirati Therapeutics Inc.
Phase 2
170
Nice, Strasbourg, Pessac, Besançon, La Tronche, Saint-Herblain, Angers, Bron
2026-05-06
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice, Marseille
2026-04-30
Recruiting
Calcium Isotope Ratios to Assess Calcium Bone Balance in Dialysis Children Receiving Cinacalcet
NCT07007338Children Over 3 Undergoing Dialysis With Secondary Hyperparathyroidism
Hospices Civils de Lyon
Observational
20
Bordeaux, Bron, Montpellier, Nice, Paris, Strasbourg
2026-04-29
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
40
Nice
2026-04-20
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
290
Nice
2026-04-15
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
120
Nice
2026-04-14
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
60
Nice
2026-04-13
Recruiting
Merck Sharp & Dohme LLC
Phase 3
758
Nice, Marseille, Toulouse, Angers, Le Mans, Saint Priest En Jarez, Villejuif
2026-04-09
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
15
Nice
2026-04-07
Recruiting
Fondation Lenval
Observational
100
Nice
2026-04-07
Recruiting
Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
NCT07428499Hereditary Angioedema (HAE), Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2, HAE
ADARx Pharmaceuticals, Inc.
Phase 3
90
Nice, Tours, Montpellier, Paris
2026-04-02
Not yet open
Charite University, Berlin, Germany
Phase 3
750
Nice
2026-04-01
Recruiting
Evaluation of Oral Collagen Peptides on Skin Barrier Function in Women
NCT07529249Dry Skin, Sensitive Skin, Dry Skin in the Elderly, Dietary Supplement
Centre de Pharmacologie Clinique Applique a la Dermatologie
Not applicable
75
Nice
2026-04
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
118
Nice, Paris, Suresnes
2026-03-31
Recruiting
Otto Bock France SNC
Not applicable
77
Berck, Créteil, Dijon, Gaillac-Toulza, Garches, Lomme, Lyon, Nice
2026-03-30
Recruiting
MICROBIOTA AND BLADDER CANCER
NCT07080333Bladder (Urothelial, Transitional Cell) Cancer
Centre Hospitalier Universitaire de Nice
Not applicable
95
Cannes, Marseille, Menton, Nice, Nîmes, Paris, Rennes, Tours
2026-03-23
Recruiting
Boehringer Ingelheim
Phase 2
132
Amiens, Bordeaux, Créteil, Nice, Paris
2026-03-23
Recruiting
Recording Stress Biomarkers in Autism Spectrum Disorders
NCT07535801Autism Spectrum Disorder With Intellectual Deficiency
Universite Cote d'Azur
Observational
60
Nice
2026-03-23
Recruiting
Amgen
Phase 3
406
Nice, Pessac, Toulouse, Tours
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Lyon, Marseille, Nice, Paris, Tours
2026-03-23
Not yet open
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Observational
50
Argenteuil, Bordeaux, Garches, Levallois-Perret, Nantes, Nice, Paris, Tourcoing
2026-03-15
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice
2026-03-15
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 2
56
Nice, Paris, Bordeaux, La Réunion, Lyon
2026-03-12
Recruiting
Bristol-Myers Squibb
Phase 3
750
Nice, Pessac, Lille, Montpellier, La Tronche, Saint-Herblain, Toulouse, Villefranche-sur-Saône
2026-03-12
Active, closed
Centre Hospitalier Universitaire de Nice
Observational
200
Nice
2026-03-09
Recruiting
Novartis Pharmaceuticals
Phase 2
210
Bordeaux, Brest, Créteil, Nice, Reims, Rouen, Toulouse
2026-03-09
Recruiting
Fondation Lenval
Not applicable
120
Brest, Grasse, Nice, Toulouse
2026-03-03
Active, closed
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
NCT07288398Pulmonary Hypertension Associated With HFpEF
DrugTNX-103
Tenax Therapeutics, Inc.
Phase 3
540
Le Kremlin-Bicêtre, Montpellier, Nantes, Nice, Pau, Poitiers
2026-03-03
Not yet open
Centre Hospitalier Universitaire de Nice
Observational
245
Nice
2026-03-01
Recruiting
Center Eugene Marquis
Phase 2
80
Grenoble, Lille, Marseille, Montpellier, Nice, Rennes
2026-02-25
Active, closed
Ipsen
Phase 3
1,300
Lyon, Nice, Paris
2026-02-18
Recruiting
Boehringer Ingelheim
Phase 3
286
Amiens, Bordeaux, Brest, Créteil, Lyon, Nice, Nîmes, Paris
2026-02-16
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
150
Nice
2026-02-09
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
52
Nice
2026-02-09
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
550
Antibes, Cannes, Nice
2026-02-07
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
70
Nice
2026-02-05
Recruiting
Innovation Alzheimer
Not applicable
75
Biot, Nice
2026-02-05
Not yet open
Fondation Lenval
Phase 2
116
Nice
2026-02-05
Recruiting
Prilenia
Phase 3
500
Lille, Marseille, Nice, Paris, Tours
2026-02-01
Not yet open
Quality of Life in Hereditary and Inflammatory Peripheral Neuropathies
NCT07340749Hereditary and Inflammatory Peripheral Neuropathies
Centre Hospitalier Universitaire de Nice
Observational
60
Nice
2026-02-01
Recruiting
Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
NCT07193394Metastatic Breast Cancer ( HER2 Negative), Unresectable Breast Cancer
DrugsTucatinib·Herceptin·Trastuzumab
Institut Curie
Phase 2
20
Bordeaux, Limoges, Marseille, Nice, Nîmes, Rennes, Saint-Cloud, Toulouse
2026-01-31
Recruiting
Takeda
Phase 2
90
Nice, Marseille, Martigues, Lyon, Le Mans, Rouen
2026-01-26
Recruiting
IDEAYA Biosciences
Phase 3
520
Nice, Bordeaux, Rennes, Paris
2026-01-25
Recruiting
Fondation Lenval
Observational
60
Nice
2026-01-21
Not yet open
Centre Hospitalier Universitaire de Nice
Observational
2
Nice
2026-01-20
Recruiting
Purinergic Compounds in Pseudoxanthoma Elasticum
NCT07323082Pseudoxanthoma Elasticum
Centre Hospitalier Universitaire de Nice
Not applicable
45
Angers, Nice
2026-01-20
Recruiting
Sanofi
Phase 3
751
Amiens, Besançon, Créteil, La Tronche, Lille, Marseille, Nantes, Nice
2026-01-16
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
150
Nice
2026-01-14
Recruiting
Hôpital NOVO
Observational
346
Caen, Nice, Paris, Pontoise, Toulon, Toulouse, Villejuif
2026-01-10
Recruiting
Contineum Therapeutics
Phase 2
324
Nice, Rennes, Bobigny, Amiens, Bron
2026-01-08
Recruiting
Insmed Incorporated
Phase 3
344
Nice, Marseille, Angers, Lille, Saint Priest En Jarez, Le Kremlin-Bicêtre, Poitiers, Brest
2026-01-07
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Nice, Pessac, Caen, Dijon, Besançon, Brest, Toulouse, Montpellier
2026-01-02
Not yet open
Robotic Emergency General Surgery Program
NCT07202442Emergency General Surgery
Centre Hospitalier Universitaire de Nice
Observational
30
Nice
2026-01-01
By invitation
Centre Hospitalier Universitaire de Nice
Observational
1,000
Nice
2026-01-01
Recruiting
Post-market Clinical Follow-up Study of NEMOST V2
NCT07403084Scoliosis Neuromuscular, Scoliosis Idiopathic, Consent Forms
EUROS
Not applicable
140
Nice, Bordeaux, Lyon, Paris
2025-12-19
Recruiting
Centre Hospitalier Universitaire de Nīmes
Not applicable
84
Nice, Nîmes
2025-12-12
By invitation
Attitudes and Perceptions of Corresponding Authors From Top International Medical Journals Regarding the Use of Artificial Intelligence in the Scientific Process
NCT07326501Artificial Intelligence, Biomedical Research, Scientific Publishing, Surveys and Questionnaires
Centre Hospitalier Universitaire de Nice
Observational
500
Nice
2025-12-10
Recruiting
Incyte Corporation
Phase 3
466
Avignon, Bordeaux, Chambray-lès-Tours, La Roche-sur-Yon, La Tronche, Lyon, Marseille, Nice
2025-12-09
By invitation
RVU120 Rollover Study
NCT06987058Advanced Solid Tumors, Acute Myeloid Leukaemia (AML), High-risk Myelodysplastic Syndrome
DrugsRVU120·Ruxolitinib
Ryvu Therapeutics SA
Phase 2
14
Nice, Pessac
2025-12-04
Recruiting
Friedreich Ataxia Nerve Ultrasund
NCT07508631Friedreich Ataxia
Centre Hospitalier Universitaire de Nice
Observational
14
Nice
2025-12-01
Recruiting
Eli Lilly and Company
Phase 3
7,140
Bois-Guillaume, Clermont-Ferrand, La Tronche, Le Coudray, Lyon, Mulhouse, Nantes, Nice
2025-12-01
Recruiting
Amgen
Phase 3
750
Bordeaux, Caen, Clermont-Ferrand, Le Mans, Lyon, Nice, Paris, Strasbourg
2025-11-28
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
38
Nice
2025-11-27
Recruiting
Fluid Administration in Ketoacidosis (DRINK)
NCT06541535Diabetic Keto-acidosis
Centre Hospitalier Universitaire de Nice
Phase 4
300
Nice
2025-11-26
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
30
Nice, Bron, Garches, Le Kremlin-Bicêtre, Lille, Marseille, Strasbourg, Toulouse
2025-11-26
Recruiting
Syndax Pharmaceuticals
Phase 3
468
Nice, Strasbourg, Marseille, Caen, Rouen, Limoges, Angers, Lille
2025-11-25
By invitation
Celldex Therapeutics
Phase 3
1,370
Nantes, Nice
2025-11-25
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Nab-paclitaxel·Pemetrexed
AstraZeneca
Phase 1/2
152
Bordeaux, Dijon, Limoges, Marseille, Nantes, Nice, Paris
2025-11-24
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
95
Nice
2025-11-24
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
160
Nice
2025-11-21
Active, closed
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
NCT07087054Carcinoid Syndrome, Carcinoid, Carcinoid Tumor, Carcinoid Tumor of Ileum
Crinetics Pharmaceuticals Inc.
Phase 3
141
Chambray-lès-Tours, Clichy, Marseille, Nantes, Nice, Paris, Pessac, Toulouse
2025-11-19
Recruiting
Summit Therapeutics
Phase 3
600
Bordeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Nice, Paris
2025-11-18
Recruiting
UCB Biopharma SRL
Phase 3
320
Lyon, Nice, Toulon
2025-11-14
Recruiting
Incyte Corporation
Phase 3
250
Argenteuil, Bordeaux, Créteil, Lyon, Nantes, Nice, Paris, Reims
2025-11-13
Active, closed
Novartis Pharmaceuticals
Phase 2
34
Antony, Dijon, Martigues, Nice
2025-11-10
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 2
65
Nice, Nantes, Pierre-Bénite, Dijon, Lille, Marseille, Montpellier, Paris
2025-11-06
Recruiting
AbbVie
Phase 3
561
Nice, Lyon, Bordeaux, Nantes, Écully, Créteil, Marseille, Paris
2025-11-05
Recruiting
Takeda
Phase 2
200
Bordeaux, Créteil, Le Mans, Martigues, Nice, Toulouse
2025-11-03
Recruiting
Eli Lilly and Company
Phase 3
1,205
Angers, Chambray-lès-Tours, Lomme, Nice, Paris, Rennes
2025-10-31
Recruiting
Shionogi
Phase 2
45
Bron, Garches, Marseille, Nice
2025-10-30
Recruiting
Hoffmann-La Roche
Phase 3
600
Angers, Bobigny, Bron, Caen, Lyon, Montpellier, Nice, Paris
2025-10-24
Recruiting
A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
NCT07785180Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc.
Observational
140
Besançon, Bobigny, Bordeaux, Créteil, Nice, Paris, Poitiers, Tours
2025-10-17
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
100
Nice
2025-10-16
Recruiting
Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders
NCT07237009Neurocognitive Disorders, Mild, Cognitive Impairment, Mild, Depression Mild, Apathy
KompanionCare SAS
Observational
80
Angers, Limoges, Nice, Paris, Tours
2025-10-14
Recruiting
University Hospital, Clermont-Ferrand
Not applicable
42
Amiens, Clermont-Ferrand, Lille, Lyon, Marseille, Montpellier, Nice, Toulouse
2025-10-13
Recruiting
Sanofi
Phase 3
980
Lille, Nice, Vandœuvre-lès-Nancy
2025-10-08
Recruiting
Bristol-Myers Squibb
Phase 3
424
Nice, Clermont-Ferrand, Marseille, Montpellier, Paris
2025-10-08
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Nice, Strasbourg, Bordeaux, Lyon Cedex08, Brest, Suresnes, Saint-Herblain, Marseille
2025-09-30
Recruiting
TRB Chemedica International SA
Not applicable
80
Brest, Le Kremlin-Bicêtre, Nice
2025-09-25
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
Nantes, Nice, Rennes, Saint-Pierre (La Réunion)
2025-09-22
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 4
50
Nice, Créteil, Garches, Grenoble, Lille, Marseille, Nancy, Rouen
2025-09-19
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
30
Créteil, Nice, Toulouse
2025-09-19
Recruiting
Zydus Therapeutics Inc.
Phase 2
240
Clermont-Ferrand, Limoges, Montpellier, Nice, Paris, Tours
2025-09-17
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
DrugEmpasiprubart
argenx
Phase 3
160
Lille, Paris, Créteil, Bourdeaux, Nice
2025-09-16
Recruiting
Pfizer
Phase 3
140
Bron, Dijon, Lille, Nice, Toulouse
2025-09-10
Recruiting
Association Francaise pour la Recherche Thermale
Not applicable
35
Nice
2025-09-05
Recruiting
University Hospital, Toulouse
Observational
200
Amiens, Lille, Lyon, Montpellier, Nantes, Nice, Rouen, Toulouse
2025-09-03
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
735
Nice
2025-09-03
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Dijon, Epagny Metz-Tessy, La Tronche, Lille, Lyon, Nantes, Nice, Paris
2025-09-02
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
NCT06960213Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2
ADARx Pharmaceuticals, Inc.
Phase 3
90
Nice, Tours, Grenoble, Montpellier, Paris
2025-08-28
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
NCT06920004Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
DrugsEmpasiprubart·IVIG
argenx
Phase 3
218
Marseille, Paris, Bordeaux, Le Kremlin-Bicêtre, Nice, Strasbourg, Toulouse
2025-08-22
By invitation
Rede Optimus Hospitalar SA
Not applicable
620
Nice, Toulouse
2025-08-08
Recruiting
AbbVie
Phase 1
135
Nice, Marseille, Lille, Tours, Toulouse
2025-08-07
Recruiting
AstraZeneca
Phase 3
700
Angers, Bordeaux, Caen, Clermont-Ferrand, Le Mans, Marseille, Montpellier, Nice
2025-08-06
Active, closed
Pfizer
Phase 3
208
Bron, Dijon, Lille, Nice, Toulouse
2025-07-31
Recruiting
Free for Weaning ECMO vs Respiratory Driven Study
NCT06876415ARDS (Acute Respiratory Distress Syndrome)
Assistance Publique Hopitaux De Marseille
Not applicable
50
Lyon, Marseille, Nice, Paris
2025-07-29
Recruiting
Amgen
Phase 3
12,800
Besançon, Dijon, Grenoble, Le Coudray, Le Creusot, Lyon, Marseille, Nice
2025-07-25
Recruiting
CongenItal Naevus Cohort for Longitudinal Evaluation
NCT06828822Naevi, Neurodevelopmental Disorder, Congenital Nevus
Nantes University Hospital
Not applicable
819
Nice, Marseille, Dijon, La Réunion, Brest, Bordeaux, Toulouse, Rennes
2025-07-23
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 2
40
Nice, Lyon, Marseille, Martigues, Saint-Etienne, Toulon, Villeurbanne
2025-07-22
Recruiting
4D Molecular Therapeutics
Phase 3
480
Nice, Marseille, Nantes
2025-07-22
Recruiting
Oral Arsenic (ATO) in Low-risk Myelodysplastic Syndromes (MDS)
NCT06670222Low-risk Myelodysplastic Syndromes
DrugArsenic Trioxide
Groupe Francophone des Myelodysplasies
Phase 1
24
Nice, Paris, Villejuif
2025-07-22
Recruiting
Mental Health and Innovation for French Higher-education Students
NCT07800585Mental Health, Neurodevelomental Disorders
O-Kidia
Observational
13,710
Nice
2025-07-21
Recruiting
Bristol-Myers Squibb
Phase 3
450
Nice, Clermont-Ferrand, Montpellier
2025-07-18
Recruiting
Merck Sharp & Dohme LLC
Phase 3
477
Nice, Caen, Toulouse, Limoges, Vandœuvre-lès-Nancy, Reims, Angers, Rouen
2025-07-16
Active, closed
Aligos Therapeutics
Phase 2
200
Clichy, Limoges, Nice, Toulouse
2025-07-15
Recruiting
Bristol-Myers Squibb
Phase 3
586
Nice, Toulouse, Rouen, Montpellier, Reims, Villeurbanne, Dijon
2025-07-14
Active, closed
Novartis Pharmaceuticals
Phase 2
168
Nice, Marseille, Quint-Fonsegrives, Suresnes
2025-07-07
Active, closed
Sanofi
Phase 2
105
Lille, Montpellier, Nice, Pierre-Bénite, Saint-Priest-en-Jarez, Toulouse
2025-07-07
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
40
Bordeaux, Nice, Villejuif
2025-07-02
Recruiting
Evaluation of Remote Photoplethysmography to Assist Vital Signs Measure in Pediatrics
NCT06231654Using Remote Photoplethysmography for Physiological Parameters
Fondation Lenval
Not applicable
600
Nice
2025-07-02
Recruiting
National Institute of Oncology, Hungary
Not applicable
250
Lyon, Nancy, Nice
2025-07-01
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
250
Nice
2025-07-01
Not yet open
Centre Hospitalier Universitaire de Nice
Observational
70
Nice
2025-07-01
Recruiting
Eli Lilly and Company
Phase 3
290
Échirolles, La Roche-sur-Yon, Le Kremlin-Bicêtre, Montpellier, Neuilly-sur-Seine, Nice, Paris, Rouen
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
350
Échirolles, La Roche-sur-Yon, Le Kremlin-Bicêtre, Montpellier, Neuilly-sur-Seine, Nice, Paris, Saint-Priest-en-Jarez
2025-06-26
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Amiens, Béziers, Bron, Dijon, Lille, Montpellier, Nantes, Nice
2025-06-25
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice, Colmar, Paris
2025-06-25
Recruiting
INNODIA Family & Friends Early-Stage T1D Detection Protocol
NCT07118098Type 1 Diabetes (T1D), Pre Diabetes
INNODIA iVZW
Observational
30,000
Angers, Bobigny, Bondy, Corbeil-Essonnes, Lyon, Nice, Paris, Vandœuvre-lès-Nancy
2025-06-25
Active, closed
Incyte Corporation
Phase 3
580
Bordeaux, Brest, Nantes, Nice, Paris
2025-06-23
Recruiting
Novartis Pharmaceuticals
Phase 3
400
Bordeaux, Clermont-Ferrand, Lille, Marseille, Nice, Nîmes, Paris, Poitiers
2025-06-23
Recruiting
GlaxoSmithKline
Phase 3
981
Saint-Quentin, Marseille, Amiens, Blois, Caen, La Tronche, Lyon, Nice
2025-06-20
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice
2025-06-19
Recruiting
Step Pharma, SAS
Phase 2
50
Poitiers, Brest, Marseille, Nantes, Nice, Nîmes, Paris, Villejuif
2025-06-18
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice
2025-06-18
Active, closed
AbbVie
Phase 3
573
Nice, Montpellier, Créteil, St-Priest-en-Jarez, Paris
2025-06-17
Recruiting
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
NCT07038200Facioscapulohumeral Muscular Dystrophy, FSHD, FSHD - Facioscapulohumeral Muscular Dystrophy, FSHD1
DrugDel-brax
Avidity Biosciences, Inc.
Phase 3
200
Marseille, Montpellier, Nice, Paris
2025-06-10
Recruiting
Centre Antoine Lacassagne
Phase 2
42
Nice
2025-06-10
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Amiens, Créteil, Lille, Lyon, Montpellier, Nice, Paris, Pessac
2025-06-09
Recruiting
GlaxoSmithKline
Phase 2
80
Le Mans, Nice, Paris, Poitiers, Toulouse
2025-06-05
Active, closed
Incyte Corporation
Phase 3
9
Amiens, Caen, Lille, Marseille, Nantes, Nice, Paris, Pessac
2025-06-04
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Angers, Clermont-Ferrand, Lille, Marseille, Montpellier, Nice, Paris, Pierre-Bénite
2025-06-04
Recruiting
Sanofi
Phase 2
99
Montpellier, Nice, Toulouse
2025-06-03
Active, closed
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
NCT07037277HEPATITIS C VIRUS CHRONIC INFECTION, Hepatitis C, Chronic, Hepatitis C Virus Infection, Hepatitis C
DrugsBemnifosbuvir-Ruzasvir·BEM/RZR·Sofosbuvir-Velpatasvir
Atea Pharmaceuticals, Inc.
Phase 3
880
Nice, Strasbourg, Clichy, Montpellier, Clermont-Ferrand, Créteil
2025-06-02
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
80
Dinan, Nice
2025-06-01
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
10
Nice
2025-06-01
Active, closed
Centre Hospitalier Universitaire de Nice
Observational
245
Nice
2025-06-01
Recruiting
Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune Disorders
NCT07037732Autoimmune Cytopenia, Connective Tissue Disorder, Systemic Vasculitis
Centre Hospitalier Universitaire de Nice
Observational
50
Nice
2025-06-01
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
40
Nice
2025-06-01
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
60
Nice
2025-06
Recruiting
Merck Sharp & Dohme LLC
Phase 2
160
Nice, Paris, Villejuif
2025-05-29
Recruiting
AbbVie
Phase 2
110
Caen, Plérin, Vandœuvre-lès-Nancy, Lille, Nice, Pierre-Bénite, La Roche-sur-Yon, Paris
2025-05-28
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Marseille, Nantes, Nice, Pierre-Bénite, Saint-Etienne
2025-05-27
Recruiting
Eikon Therapeutics
Phase 2/3
740
Pierre-Bénite, Boulogne, La Tronche, Lille, Marseille, Nice, Paris, Saint-Herblain
2025-05-22
Recruiting
University Hospital, Brest
Not applicable
250
Brest, Amiens, Angers, Bordeaux, Marseille, Nantes, Nice, Rouen
2025-05-15
Recruiting
Takeda
Phase 3
225
Nice, Paris, Poitiers, Toulouse
2025-05-06
Recruiting
AstraZeneca
Phase 3
1,220
Clichy, Lille, Lyon, Montpellier, Nantes, Nice, Pessac, Rennes
2025-05-06
Active, closed
Mediar Therapeutics
Phase 2
168
Nantes, Nice, Rennes
2025-05-05
Recruiting
Centre Antoine Lacassagne
Not applicable
50
Nice
2025-05-02
Recruiting
Impact of an e-Bug Educational Intervention on HPV Vaccine Uptake in Middle School Students
NCT07266857Papillomavirus Infection, Papillomavirus Vaccines, Vaccination Coveage
Centre Hospitalier Universitaire de Nice
Observational
11,000
Nice
2025-05-01
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
90
Nice
2025-04-30
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Phase 3
128
Bordeaux, Garches, Lille, Lyon, Nice, Paris, Strasbourg, Toulouse
2025-04-29
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 3
420
Nice, Bordeaux, Nantes, Rouen, Sainte-Maxime, Argenteuil, Brest, Cenon
2025-04-29
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
1,000
Nice
2025-04-23
Active, closed
Merck Sharp & Dohme LLC
Phase 2
440
Nice, Montpellier, Saint-Herblain, Angers, Rouen, Le Kremlin-Bicêtre
2025-04-16
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
400
Nice
2025-04-15
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
60
Nice
2025-04-14
Recruiting
AbbVie
Phase 2
120
Nice, Caluire-et-Cuire, Chambray-lès-Tours, Bordeaux, Orléans
2025-04-11
Active, closed
University Hospital, Tours
Observational
80
Brest, Clermont-Ferrand, Lille, Limoges, Lyon, Nice, Tours
2025-04-11
Recruiting
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
NCT06906341Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms, Endometrial Cancer
DrugsNab-paclitaxel /m^2·Relacorilant·Bevacizumab
Corcept Therapeutics
Phase 2
270
Lille, Nancy, Nice, Pierre-Bénite, Plérin, Toulouse
2025-04-11
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
74
Nice
2025-04-01
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
300
Bordeaux, Le Kremlin-Bicêtre, Marseille, Montpellier, Nice, Paris
2025-04-01
Recruiting
UNICANCER
Phase 2
40
Brest, Nice, Paris, Poitiers, Saint-Priest-en-Jarez, Vandœuvre-lès-Nancy
2025-03-27
Recruiting
Eli Lilly and Company
Phase 3
700
Bron, La Tronche, Lyon Cedex08, Marseille, Nice, Paris, Pessac, Poitiers
2025-03-27
Recruiting
AstraZeneca
Phase 3
600
Besançon, Bordeaux, Caen, Clermont-Ferrand, Lyon, Montpellier, Nice, Paris
2025-03-27
Recruiting
Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR)
NCT07083089Mild Cognitive Impairment (MCI) Amnestic, Parkinson Disease (PD), Healthy Participants
Cilcare SAS
Not applicable
309
Montpellier, Nice, Nîmes, Villeurbanne
2025-03-24
Recruiting
Evaluation of Urinary Dysfunction in CANVAS Patients
NCT06817707Cerebellar Ataxia, Neuropathy, Vestibular Areflexia
Centre Hospitalier Universitaire de Nice
Not applicable
40
Nice, Montpellier, Lille
2025-03-21
Active, closed
Astria Therapeutics, Inc.
Phase 3
157
La Tronche, Lille, Marseille, Nice, Paris
2025-03-20
Active, closed
Novartis Pharmaceuticals
Phase 3
565
Nice, Brest, La Rochelle, Lyon, Reims, Rouen, Toulouse
2025-03-20
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice
2025-03-19
Recruiting
Validation of a Rapid Screening Tool for Anxiety-depressive Disorders in Children, Adolescents and Young Adults Treated in Oncology. Multicenter Study.
NCT07117058Generalized Anxiety, Introspective & Anxiety-Prone Patient, Depression, Anxiety, Survivors of Childhood Cancer
Centre Hospitalier Universitaire de Saint Etienne
Observational
545
Angers, Caen, Grenoble, Lyon, Nice, Rouen, Saint-Etienne
2025-03-18
Recruiting
Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome
NCT06831253Severe Dry Eye Syndromes, Dry Eye Syndromes
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice
2025-03-17
Recruiting
Fondation Lenval
Observational
20
Nice
2025-03-17
Recruiting
Hoffmann-La Roche
Phase 3
600
Amiens, Marseille, Nice, Pessac, Reims, Rennes, Saint-Etienne
2025-03-17
Active, closed
Celgene
Phase 3
960
Nice, Dijon, Toulouse, Vandœuvre-lès-Nancy, Pierre-Bénite, Le Mans, Villejuif, Clermont-Ferrand
2025-03-13
Recruiting
Societe Francaise de Rhumatologie
Not applicable
112
Créteil, Dijon, Grenoble, Lomme, Marseille, Nice, Nîmes, Paris
2025-03-10
Recruiting
AbbVie
Phase 1/2
252
Bordeaux, Saint-Herblain, Montpellier, Nice, Villejuif, Paris
2025-03-06
Recruiting
Volta Medical
Observational
278
Bron, Clermont-Ferrand, Lomme, Marseille, Massy, Nantes, Nice, Saint-Denis
2025-03-06
Recruiting
Centre Antoine Lacassagne
Not applicable
238
Nice
2025-03-03
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
55
Nice
2025-03-01
Not yet open
Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children
NCT06604975Primary Polydipsia, Central Diabetes Insipidus, Nephrogenic Diabetes Insipidus
Assistance Publique Hopitaux De Marseille
Not applicable
155
Angers, Bordeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Nice
2025-03
Recruiting
Incyte Corporation
Phase 3
600
Antony, Bordeaux, Brest, Créteil, Lyon, Marseille, Nantes, Nice
2025-02-28
Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
NCT06517875Primary Myelofibrosis, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
DrugsMomelotinib·Reblozyl·Luspatercept
GlaxoSmithKline
Phase 2
68
Angers, Brest, Lyon, Nice, Nîmes, Paris, Poitiers
2025-02-28
Recruiting
Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases
NCT06435468Systemic Lupus, Autoimmune Diseases, Autoinflammatory Disease, Genetic Disease
Hospices Civils de Lyon
Not applicable
400
Bron, Lille, Nice, Paris, Saint-Etienne, Grenoble, Rouen, Strasbourg
2025-02-26
Recruiting
Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma
NCT06706401Oropharynx Cancer, Larynx Cancer, Hypopharynx Cancer, Primary Head and Neck Tumor
DrugsVesanoid·ATRA·Cetuximab·Cisplatin
Centre Leon Berard
Phase 3
460
Lyon, Vandœuvre-lès-Nancy, Villejuif, Angers, Lille, Nice, Paris, Reims
2025-02-20
Recruiting
Menarini Group
Phase 2
44
Nantes, Nice, Paris, Tours
2025-02-18
Recruiting
Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants
NCT06823466Ischemic Stroke, Oral Anticoagulation, Atrial Fibrillation (AF), Outcome Assessment
University of L'Aquila
Observational
200
Nice
2025-02-12
Recruiting
Dianthus Therapeutics
Phase 3
256
Bordeaux, Brest, Bron, Clermont-Ferrand, Libourne, Marseille, Nice, Paris
2025-02-10
Active, closed
Genmab
Phase 3
584
Nice, Paris, Pierre-Bénite, Rennes, Saint-Herblain, Toulouse, Villejuif
2025-02-07
Active, closed
Novartis Pharmaceuticals
Phase 3
180
Bordeaux, Nice, Paris, Strasbourg, Toulouse
2025-02-07
Recruiting
Assistance Publique Hopitaux De Marseille
Not applicable
48
Marseille, Nice
2025-02-06
Recruiting
LEO Pharma
Phase 3
90
Antony, Lyon, Nice, Paris
2025-02-05
Recruiting
Bristol-Myers Squibb
Phase 1/2
416
Nice, Bordeaux, Lyon, Marseille, Caen, Montpellier, Villejuif, Paris
2025-02-04
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 3
120
Besançon, Bordeaux, Caen, Créteil, Lyon, Marseille, Nice, Nîmes
2025-02-04
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
200
Nice
2025-02-03
Recruiting
Airway Therapeutics, Inc.
Phase 2/3
366
Lille, Nancy, Nice, Paris, Poissy
2025-02-03
Recruiting
AbbVie
Observational
1,200
Nice, Caluire-et-Cuire, Clermont-Ferrand, Échirolles, Besançon, Arras, Lille, Montpellier
2025-01-31
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Nice, La Rochelle, Dijon, La Tronche, Limoges, Metz, Dunkirk, Clermont-Ferrand
2025-01-27
Recruiting
Ascentage Pharma Group Inc.
Phase 3
490
Angers, Le Mans, Limoges, Nantes, Nice, Orléans, Paris, Pessac
2025-01-22
Recruiting
Incyte Corporation
Phase 3
240
Amiens, Marseille, Nancy, Nantes, Nice, Paris, Pierre-Bénite, Toulouse
2025-01-21
Recruiting
TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis
NCT06818058EGFR Inhibitor-associated Rash
Tarian Pharma
Phase 2
60
Lyon, Marseille, Nice
2025-01-20
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
10
Nice
2025-01-15
Not yet open
University Hospital, Bordeaux
Not applicable
252
Bordeaux, Boulogne-Billancourt, Castelnau-le-Lez, Dijon, Grenoble, Lyon, Nice, Paris
2025-01-15
Recruiting
Centre Leon Berard
Not applicable
236
Angers, Besançon, Bordeaux, Caen, Lille, Lyon, Nancy, Nice
2025-01-14
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
10
Nice, Montpellier
2025-01-09
Active, closed
Centre Antoine Lacassagne
Not applicable
19
Nice
2025-01-09
Active, closed
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis
Alumis Inc
Phase 3
1,680
Nice, Rouen
2025-01-08
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Argenteuil, Caen, Le Mans, Mulhouse, Nice, Tours
2025-01-03
Not yet open
Centre Hospitalier Universitaire de Nice
Observational
500
Nice
2025-01-01
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
48
Nice
2025-01-01
Active, closed
Predicting NOM Failure in Bowel Obstruction
NCT06711107Small Bowel Obstruction, Intestinal Pseudo-Obstruction
Centre Hospitalier Universitaire de Nice
Observational
370
Nice
2025-01-01
Active, closed
argenx
Phase 3
154
Bordeaux, Brest, Bron, Le Kremlin-Bicêtre, Lille, Limoges, Marseille, Nice
2024-12-18
Recruiting
Centre Hospitalier Universitaire de Nīmes
Observational
32
Montpellier, Nice, Nîmes, Toulouse
2024-12-12
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
30
Nice
2024-12-10
Recruiting
Nantes University Hospital
Not applicable
350
Besançon, Brest, Créteil, Grenoble, Nantes, Nice, Reims
2024-12-10
Active, closed
Amgen
Phase 3
707
Bordeaux, Clermont-Ferrand, La Tronche, Le Mans, Lille, Lyon, Marseille, Nice
2024-12-09
Recruiting
Covid-19 Long Immunité IMagerie (CLIIM)
NCT06528171COVID Long-Haul
Centre Hospitalier Universitaire de Nice
Not applicable
200
Nice
2024-12-06
Recruiting
Institut de Recherches Internationales Servier
Phase 3
48
Nantes, Nice, Paris, Pessac, Toulouse, Vandœuvre-lès-Nancy
2024-12-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,380
Nice, Neuilly-sur-Seine, Vandœuvre-lès-Nancy, Lille
2024-11-25
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
48
Nice
2024-11-18
Recruiting
Centre Leon Berard
Not applicable
100
Angers, Bourg-en-Bresse, Dijon, Grenoble, Lyon, Marseille, Nice, Saint-Herblain
2024-11-15
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
290
Nice, Paris
2024-11-11
Recruiting
Anti-GD2 ADC M3554 in Advanced Solid Tumors
NCT06641908Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc.
Phase 1
65
Bordeaux, Lille, Lyon, Nice
2024-11-08
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice
2024-11-04
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Phase 4
220
Le Kremlin-Bicêtre, Amiens, Lille, Limoges, Marseille, Montpellier, Nice, Paris
2024-10-31
Recruiting
Regeneron Pharmaceuticals
Phase 3
975
Nice, Marseille, Poitiers, Toulouse, Créteil, Dijon, Lille, Lyon
2024-10-30
Recruiting
Peridontal and Intestinal Microbiota in Patients With Gingival Scarring Pemphigoid
NCT06291350Pemphigoid, Benign Mucous Membrane, Gingivitis Hyperplastic
Centre Hospitalier Universitaire de Nice
Observational
45
Nice, Paris
2024-10-24
Recruiting
Novartis Pharmaceuticals
Phase 1/2
232
Angers, Brest, Clamart, Grenoble, Montpellier, Nice, Pessac, Poitiers
2024-10-24
Recruiting
United Pharmaceuticals
Not applicable
139
Nice, Paris, Toulon, Vincennes
2024-10-21
Active, closed
Institut Claudius Regaud
Phase 2
86
Amiens, Avignon, Bordeaux, Clermont-Ferrand, Limoges, Marseille, Nantes, Nice
2024-10-21
Active, closed
Pfizer
Phase 3
600
Nice, Lyon Cedex08, Strasbourg, Brest, Nîmes, Toulouse, Lille, Suresnes
2024-10-21
Active, closed
Novartis Pharmaceuticals
Phase 2
251
Bron, Lille, Nice, Paris, Tours
2024-10-17
Active, closed
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
NCT05720910Breast Cancer, Comorbidities and Coexisting Conditions, Lung Cancer, Colorectal Cancer
Institut Bergonié
Not applicable
720
Bayonne, Bordeaux, Dinan, La Roche-sur-Yon, Lyon, Mougins, Nice, Paris
2024-10-15
Active, closed
MoonLake Immunotherapeutics AG
Phase 3
600
Caluire-et-Cuire, Montpellier, Narbonne, Nice, Rouen, Tours
2024-10-15
Active, closed
MoonLake Immunotherapeutics AG
Phase 3
960
Cahors, Caluire-et-Cuire, Échirolles, Montpellier, Narbonne, Nice, Rouen, Tours
2024-10-15
Active, closed
Eli Lilly and Company
Phase 2
143
Créteil, Grenoble, La Roche-sur-Yon, Nice, Pierre-Bénite, Rouen
2024-10-10
Active, closed
Gilead Sciences
Phase 3
609
Bourdeaux, Le Kremlin-Bicêtre, Marseile, Nice
2024-10-09
Active, closed
Gilead Sciences
Phase 2
268
Bobigny, Marseille, Nice, Paris
2024-10-07
Recruiting
Stemline Therapeutics, Inc.
Phase 3
4,220
Besançon, Nice, Strasbourg, Grenoble, Valenciennes, Montpellier, Chambray-lès-Tours, Limoges
2024-09-27
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Nice, Tours, Toulouse
2024-09-26
Active, closed
Merus B.V.
Phase 3
699
Bordeaux, Le Mans, Lille, Lyon, Marseille, Montpellier, Nice, Paris
2024-09-25
Active, closed
Hoffmann-La Roche
Phase 3
338
Brest, Bron, Lille, Lyon, Montpellier, Nice, Paris, Pessac
2024-09-23
Active, closed
Hoffmann-La Roche
Phase 3
400
Amiens, Dijon, La Roche-sur-Yon, Lille, Marseille, Neuilly-sur-Seine, Nice, Pessac
2024-09-17
Recruiting
University Hospital, Limoges
Not applicable
1,000
Lille, Limoges, Marseille, Montpellier, Nice, Paris, Tours
2024-09-17
Active, closed
Novo Nordisk A/S
Phase 4
500
Lille, Nice, Paris, Rouen, Toulouse
2024-09-17
Active, closed
GCP-Service International West GmbH
Phase 2
41
Grenoble, Nice, Paris, Pessac, Toulouse
2024-09-10
Recruiting
AbbVie
Phase 2
590
Nice, Montpellier, Rennes, Vandœuvre-lès-Nancy, Pessac, Toulouse, St-Priest-en-Jarez, Pierre-Bénite
2024-09-04
Recruiting
Gossamer Bio USA, Inc.
Phase 3
330
Le Kremlin-Bicêtre, Lille, Nice, Poitiers
2024-09-03
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
114
Nice
2024-09-01
Not yet open
Centre Hospitalier Universitaire de Nice
Not applicable
102
Nice, Cannes
2024-09
Active, closed
Sanofi
Phase 2
229
Nice, Paris
2024-08-29
Active, closed
Gilead Sciences
Phase 3
640
Caen, Marseille, Nice, Paris, Pierre-Bénite, Saint-Herblain, Vandœuvre-lès-Nancy, Villejuif
2024-08-28
Recruiting
Sanofi
Phase 3
160
Le Kremlin-Bicêtre, Lille, Marseille, Nice, Paris
2024-08-21
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
264
Saint-Herblain, Vandœuvre-lès-Nancy, Lyon, Montpellier, Nice, Nîmes, Paris, Toulouse
2024-08-09
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 2
20
Nice, Paris, Toulouse
2024-08-06
Recruiting
AbbVie
Phase 3
170
Metz, Créteil, Paris, St-Priest-en-Jarez, Nice, Bayonne, Chambéry, Amiens
2024-08-05
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Limoges, Garches, Nice, Paris
2024-07-31
Active, closed
Annexon, Inc.
Phase 3
659
Bordeaux, Créteil, Dijon, Écully, Marseille, Nice, Paris, Strasbourg
2024-07-30
Recruiting
Assistance Publique Hopitaux De Marseille
Not applicable
210
Bayonne, Bordeaux, La Rochelle, Les Sables-d'Olonne, Marseille, Montpellier, Nantes, Nice
2024-07-24
Active, closed
Vor Biopharma
Phase 3
191
Nice, Bordeaux
2024-07-17
Recruiting
Amgen
Phase 3
450
Clermont-Ferrand, Créteil, Dijon, Lyon, Montpellier, Nice, Paris, Pessac
2024-07-17
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Nice, Pessac, Marseille, Toulouse, Limoges, Tours, Nantes, Pierre-Bénite
2024-07-16
Recruiting
Replimune, Inc.
Phase 3
400
Bordeaux, Lille, Marseille, Nice, Paris, Pierre-Bénite, Villejuif
2024-07-11
Active, closed
Celldex Therapeutics
Phase 3
963
Pierre-Bénite, La Tronche, Martigues, Nantes, Nice, Paris, Rouen
2024-07-11
Not yet open
DIAMPARK
Not applicable
300
Angers, Bourg-en-Bresse, Caen, Clamart, Le Puy-en-Velay, Montpellier, Nice, Troyes
2024-07-01
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Nice, Strasbourg, La Tronche, Paris, Clermont-Ferrand, Bron, Créteil
2024-06-25
Active, closed
Merus B.V.
Phase 3
621
Bordeaux, Brest, Le Mans, Lille, Lyon, Marseille, Montpellier, Nice
2024-06-25
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Nice, Bayonne, Guilherand-Granges, Lyon Cedex08, Clermont-Ferrand, Marseille, Caen, Dijon
2024-06-24
Active, closed
Celgene
Phase 3
850
Nice, Strasbourg, Bordeaux, Pessac, Marseille, Dijon, Besançon, Brest
2024-06-19
Active, closed
Ivy Brain Tumor Center
Phase 3
450
Nice, Marseille, Montpellier, Rennes, Saint-Herblain, Paris, Bron, Lyon
2024-06-19
Recruiting
Nutricia Nutrition Clinique
Observational
3,000
Nice, Paris
2024-06-17
Active, closed
An Evaluation of the WHO QUAlityRights Program
NCT06874439Recovery, Organization of Health Service, Mental Health Care, Mental Health Services
GCS-CCOMS
Not applicable
1,800
Armentières, Erstein, Laxou, Montéléger, Nanterre, Nice, Plaisir, Pont-du-Casse
2024-06-17
Active, closed
Novartis Pharmaceuticals
Observational
192
Nice, Antony, Bordeaux, Brest, Calais, Dijon, La Rochelle, Le Mans
2024-06-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Nice, Pessac, Marseille, Dijon, Reims, Besançon, Valence, Nîmes
2024-06-05
Recruiting
Kartos Therapeutics, Inc.
Phase 3
600
Paris, Amiens, Angers, Lille, Lyon, Nantes, Nice, Nîmes
2024-06-03
Recruiting
Inorganic Pyrophosphate Homeostasis (PPi) in Pediatric Chronic Kidney Disease
NCT06300788Pyrophosphate, Fetuin A, IL1, IL6, TNFalpha, Control
Centre Hospitalier Universitaire de Nice
Not applicable
60
Nice
2024-05-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Nice, Dijon, Nîmes, Valenciennes, Clermont-Ferrand, Avignon, Boulogne-Billancourt
2024-05-24
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,800
Amiens, Clichy, Dijon, Limoges, Lyon, Montpellier, Nice, Paris
2024-05-24
Recruiting
NMD Pharma A/S
Phase 2
84
Bordeaux, Marseille, Nantes, Nice
2024-05-16
Active, closed
Sanofi
Phase 3
1,541
Antony, Nice, Paris, Pierre-Bénite, Reims, Romans-sur-Isère, Rouen, Toulouse
2024-05-08
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
32
Nice
2024-05-06
Active, closed
Centre Hospitalier Universitaire de Nice
Phase 2
128
Nice, Paris, Bordeaux, Lille, Lyon
2024-05-05
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 3
235
Annecy, Bordeaux, Boulogne, Lyon, Marseille, Montpellier, Nantes, Nice
2024-05-02
Recruiting
Centre Hospitalier Princesse Grace
Observational
1,500
Angers, Clermont-Ferrand, Dijon, Grenoble, Lyon, Montpellier, Nantes, Nice
2024-04-19
Active, closed
argenx
Phase 3
119
Marseille, Nice, Paris
2024-04-16
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
2,722
Nice
2024-04-08
Recruiting
Centre Antoine Lacassagne
Not applicable
60
Nice
2024-04-04
Recruiting
UNICANCER
Phase 2
420
Saint-Denis, Avignon, Dijon, Lille, Marseille, Nice, Nîmes, Paris
2024-04-03
Active, closed
Takeda
Phase 2
213
Clermont-Ferrand, Nice, Saint-Etienne, Vandœuvre-lès-Nancy
2024-03-29
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
212
Avignon, Lyon, Marseille, Mâcon, Nice, Saint-Etienne, Saint-Herblain, Villejuif
2024-03-26
Recruiting
Italfarmaco
Phase 3
220
Saint-Quentin, Nice, Troyes, Tours, Nantes, Angers, Amiens, Paris
2024-03-26
Active, closed
AbbVie
Phase 2
156
Nice, Toulouse, Créteil, Nantes, St-Priest-en-Jarez
2024-03-23
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
411
Amiens, Clermont-Ferrand, Lille, Lyon, Montpellier, Nice, Paris, Saint-Herblain
2024-03-15
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
40
Nice
2024-03-06
Recruiting
Takeda
Phase 2
268
Chambray-lès-Tours, Clermont-Ferrand, Neuilly-sur-Seine, Nice, Saint-Etienne, Vandœuvre-lès-Nancy
2024-03-05
By invitation
Sarepta Therapeutics, Inc.
Phase 1/2
78
Angers, Bordeaux, Lille, Nice, Paris
2024-03-04
Recruiting
University Hospital, Strasbourg, France
Not applicable
150
Besançon, Bordeaux, Caen, Dijon, Lyon, Marseille, Nantes, Nice
2024-03-04
Not yet open
Outcome of Children With Eosinophilic Esophagitis
NCT06190080Esophagitis, Eosinophilic
Fondation Lenval
Not applicable
16
Nice
2024-03
Recruiting
Elsan
Not applicable
132
Beaumont, Caen, Essey-lès-Nancy, Lyon, Muret, Nice, Saint-Herblain, Strasbourg
2024-02-27
Recruiting
Centre Francois Baclesse
Not applicable
160
Caen, Clamart, Grenoble, Le Havre, Lyon, Nice, Paris, Saint-Cloud
2024-02-26
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
50
Nice, Paris
2024-02-26
Active, closed
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer
NCT06239467Advanced Cancer, Breast Cancer, Advanced Solid Tumors, PI3K Gene Mutation
DrugsAtirmociclib·Tucatinib·Ribociclib·Fulvestrant
OnKure, Inc.
Phase 1
200
Dijon, Lille, Lyon, Nice, Pierre-Bénite, Villejuif
2024-02-26
Active, closed
Dianthus Therapeutics
Phase 2
65
Bordeaux, Nice, Strasbourg
2024-02-23
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
36
Nice
2024-02-23
Active, closed
ViiV Healthcare
Phase 3
463
Bordeaux, Lyon, Montpellier, Nice, Nîmes, Paris
2024-02-21
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 3
404
Lille, Marseille, Nice, Paris, Villefranche-sur-Saône
2024-02-20
Active, closed
AbbVie
Observational
1,200
Nice, Clermont, Lyon, Marseille, Dijon, Pessac, Toulouse, Montpellier
2024-02-19
Active, closed
Janssen Research & Development, LLC
Phase 2
305
Marseille, Nice, Paris
2024-02-16
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 2
50
Nice
2024-02-16
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
48
Lyon, Nice, Poitiers
2024-02-09
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice
2024-02-09
Recruiting
Neurocognitive Impairment After Ischemic Stroke
NCT06262529Acute Ischemic Stroke
Centre Hospitalier Universitaire de Nice
Not applicable
16
Cannes, Nice
2024-02-08
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase
DrugsBosutinib·Olverembatinib
Ascentage Pharma Group Inc.
Phase 3
333
Amiens, Bobigny, Nice, Rouen, Toulouse
2024-02-05
Active, closed
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
NCT05853575Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung
DrugAdagrasib
Mirati Therapeutics Inc.
Phase 2
200
Grenoble, Pessac, Saint-Herblain, Angers, Lorient, Nantes, Poitiers, Nice
2024-02-01
Active, closed
Astellas Gene Therapies
Not applicable
119
Angers, Garches, Lille, Limoges, Marseille, Nantes, Nice, Strasbourg
2024-02-01
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
400
Nice
2024-01-30
Active, closed
Incyte Corporation
Phase 3
617
Bordeaux, Brest, Dijon, Le Mans, Lyon, Marseille, Nantes, Nice
2024-01-30
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
40
Nice
2024-01-24
Active, closed
Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1
NCT06222827Facioscapulohumeral Muscular Dystrophy 1
DrugSatralizumab
Centre Hospitalier Universitaire de Nice
Phase 2
46
Nice
2024-01-24
Recruiting
Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder
NCT06655129Excessive Hairiness, Vascular Lesion, Pigmented Lesions, Acne Vulgaris
Eurofeedback
Not applicable
85
Auxerre, Brest, Nice, Périgueux, Poitiers
2024-01-20
Not yet open
Early Biomarkers of Neurodegeneration in Parkinsonian Syndromes
NCT06155942Parkinson Disease, Progressive Supranuclear Palsy
Assistance Publique Hopitaux De Marseille
Not applicable
63
Aix-en-Provence, Aubagne, Avignon, Nice, Nîmes, Toulon
2024-01-15
Recruiting
Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion
NCT06247826Non-small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation
Groupe Francais De Pneumo-Cancerologie
Not applicable
30
Bordeaux, Brest, Créteil, Dijon, Grenoble, Le Mans, Marseille, Nice
2024-01-15
Recruiting
Ryvu Therapeutics SA
Phase 2
98
Grenoble, Le Mans, Lille, Marseille, Nice, Nîmes, Paris, Rouen
2024-01-05
Recruiting
University Hospital, Tours
Phase 3
374
Angers, Lyon, Nice, Nîmes, Rennes, Rouen, Toulouse, Tours
2024-01-04
By invitation
Sanofi
Phase 3
90
Créteil, Lille, Nice, Paris
2024-01-03
Recruiting
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
NCT06190899mCRPC (Metastatic Castration-resistant Prostate Cancer), Genital Diseases, Male, Urogenital Diseases, Male, Prostatic Disease
DrugsGedatolisib·Darolutamide
Celcuity Inc
Phase 1/2
54
Clermont-Ferrand, Marseille, Nice, Villejuif
2024-01-01
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 4
150
Nice
2023-12-30
Active, closed
Sanofi
Phase 3
943
Créteil, Gonesse, La Tronche, Lille, Nancy, Nice, Orsay, Paris
2023-12-27
Recruiting
Eli Lilly and Company
Phase 3
1,264
Avignon, Bron, Lille, Lyon Cedex08, Nice, Paris, Pessac, Poitiers
2023-12-21
Recruiting
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
NCT06118086Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma
DrugREM-422
Remix Therapeutics
Phase 1/2
125
Nice, Villejuif
2023-12-20
Active, closed
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
NCT06046222Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome
NS Pharma, Inc.
Phase 2
45
Nice, Paris, Toulouse
2023-12-20
Active, closed
AbbVie
Phase 3
614
Nice, Bordeaux, Toulouse, Créteil, Lyon
2023-12-19
Recruiting
Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease
NCT05800275Leptomeningeal Metastasis, Leptomeningeal Disease, HER2-positive Metastatic Breast Cancer
DrugsTucatinib·Trastuzumab·Capecitabine
UNICANCER
Phase 2
30
Bordeaux, Caen, Clermont-Ferrand, Dijon, Lyon, Montpellier, Nice, Reims
2023-12-18
Recruiting
AstraZeneca
Phase 3
1,145
Avignon, Bordeaux, Le Mans, Lyon, Nice, Saint-Herblain, Toulouse, Villejuif
2023-12-14
Active, closed
Sanofi
Phase 3
1,655
Calais, Colmar, La Tronche, Lille, Nice, Saint-Herblain
2023-12-13
Recruiting
Azathioprine in MOGAD
NCT05349006Central Nervous System Inflammation, MOG-IgG Associated Disease
DrugAzathioprine
Hospices Civils de Lyon
Phase 3
126
Bordeaux, Lille, Lyon, Marseille, Montpellier, Nancy, Nice, Nîmes
2023-12-12
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
20
Nice
2023-12-11
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
100
Nice
2023-12-08
Active, closed
Aura Biosciences
Phase 3
108
Nice, Lyon
2023-12-06
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
100
Nice
2023-12-05
Recruiting
Akero Therapeutics, Inc
Phase 3
1,650
Nice, Lyon, Strasbourg, Limoges, Clichy, Vandœuvre-lès-Nancy, Angers, Toulouse
2023-12-01
Recruiting
Clinique Saint François, Nice, France
Not applicable
50
Nice
2023-12-01
Active, closed
Incyte Corporation
Phase 3
450
Brest, Le Mans, Martigues, Nice, Rouen
2023-11-27
Active, closed
Novartis Pharmaceuticals
Phase 3
470
Nice, Grenoble, La Rochelle, Pierre-Bénite, Rouen
2023-11-15
Active, closed
AstraZeneca
Phase 3
1,902
Avignon, Bayonne, Caen, Clermont-Ferrand, Limoges, Marseille, Montpellier, Nice
2023-11-14
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
100
Nice
2023-11-13
Recruiting
University Medical Center Groningen
Observational
248
Nice
2023-11-10
Active, closed
Fondation Ophtalmologique Adolphe de Rothschild
Phase 3
244
Créteil, Gonesse, Grenoble, Limoges, Lyon, Nice, Paris, Poissy
2023-11-09
Recruiting
Institut Claudius Regaud
Not applicable
40
Montpellier, Nice, Toulouse
2023-11-08
Active, closed
AstraZeneca
Phase 3
1,835
La Tronche, Mulhouse, Nice, Nîmes, Rouen, Saint-Priest-en-Jarez, Strasbourg, Tours
2023-11-07
Recruiting
Ad scientiam
Not applicable
103
Lille, Marseille, Montpellier, Nice, Paris, Rouen, Strasbourg, Toulouse
2023-11-03
By invitation
Edgewise Therapeutics, Inc.
Phase 2
260
Marseille, Nantes, Nice, Paris
2023-11-02
Active, closed
Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation
NCT06083012Atrial Fibrillation, Atrial Arrhythmia, Arrhythmias, Cardiac
Volta Medical
Observational
186
Marseille, Massy, Nice, Saint-Denis, Strasbourg, Toulouse
2023-10-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Nice, Pessac, Marseille, Reims, Besançon, Nîmes, Clichy, Neuilly-sur-Seine
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 3
402
Nice, Pessac, Tours, La Tronche, Vandœuvre-lès-Nancy, Angers, Villejuif, Paris
2023-10-24
Recruiting
Institut Cancerologie de l'Ouest
Phase 3
274
Angers, Bordeaux, Caen, Grenoble, Limoges, Lyon, Nantes, Nice
2023-10-20
Recruiting
MED-EL Elektromedizinische Geräte GmbH
Not applicable
20
Nice
2023-10-17
Recruiting
AbbVie
Phase 3
1,500
Nice, Rennes, Bordeaux, Toulouse, Reims, Nantes, Lyon, Brest
2023-10-11
Active, closed
Clinuvel, Inc.
Phase 3
200
La Réunion, Nice
2023-10-11
Recruiting
Fluid Responsiveness Prediction During Prone Position
NCT05898269Acute Respiratory Distress Syndrome
Hospices Civils de Lyon
Not applicable
96
Clermont-Ferrand, Lyon, Nice
2023-10-06
Active, closed
Bristol-Myers Squibb
Phase 3
106
Nice, Poitiers, Angers, Grenoble, Paris, Pierre-Bénite, Tour Cedex01
2023-10-05
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
50
Nice, Marseille, Paris
2023-10-03
Recruiting
Centre Hospitalier Universitaire de Nice
Phase 4
70
Nice
2023-10-01
Active, closed
Ad scientiam
Not applicable
336
Lille, Lomme, Marseille, Nice, Rouen
2023-09-22
Active, closed
PharmaMar
Phase 3
469
Lyon, Besançon, Angers, Nice, Bordeaux, Lille, Limoges, Marseille
2023-09-21
Not yet open
Cohort Project of Patients With Inflammatory Rheumatism
NCT06059430Rheumatoid Arthritis, Spondyloarthritis, Axial, Psoriatic Arthritis
Centre Hospitalier Universitaire de Nice
Observational
1,000
Nice
2023-09-20
Recruiting
University Hospital, Montpellier
Not applicable
220
Bordeaux, Montpellier, Nice, Nîmes
2023-09-18
Recruiting
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy
NCT06029218Chordoma, Chondrosarcoma, Ewing Sarcoma, Osteosarcoma
Centre Antoine Lacassagne
Not applicable
106
Nice
2023-09-13
Active, closed
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
NCT05869955Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathy, Systemic Sclerosis, Rheumatoid Arthritis
DrugsZola-cel·Tocilizumab·Fludarabine·Cyclophosphamide
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 1
270
Pessac, Montpellier, Lille, Nice, Paris, Rennes
2023-09-13
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
55
Nice
2023-09-11
Recruiting
Biotest
Phase 3
590
Nice, Reims, Strasbourg, Colombes, Limoges, Rennes, Tours, Grenoble
2023-09-09
Recruiting
timkl
Not applicable
340
Nice
2023-09-04
Recruiting
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
NCT06051409Ph+ ALL, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
DrugOlverembatinib
Ascentage Pharma Group Inc.
Phase 3
350
Le Chesnay, Lyon, Nantes, Nice, Pessac, Pierre-Bénite, Poitiers, Toulouse
2023-08-31
Recruiting
Ipsen
Phase 3
276
Clichy, Créteil, Lille, Lyon, Marseille, Nice, Paris, Poitiers
2023-08-31
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
20
Nice
2023-07-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Nice, Marseille, Dijon, Besançon, Bordeaux, Rennes, Lille, Pierre-Bénite
2023-07-19
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
1,400
Nice, Bordeaux, Troyes, La Tronche, Lyon, Saint-Priest-en-Jarez, Voiron, Marseille
2023-07-17
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
100
Nice
2023-07-13
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Nice, Tours, Reims, Rouen, Toulouse
2023-07-11
Not yet open
Assessment and Prevention of Caregiver Burden in Oncology
NCT05750836Oncology, Caregiver Burden
Institut Cancerologie de l'Ouest
Not applicable
250
Cholet, Nice, Rouen, Saint-Herblain, Saint-Lô
2023-07
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Amiens, Lyon, Marseille, Nice, Pessac, Strasbourg
2023-06-28
Active, closed
Swedish Orphan Biovitrum
Observational
165
Nice, Pessac, Suresnes, Grenoble, Nantes, Vandœuvre-lès-Nancy, Lille, La Defense
2023-06-26
Active, closed
AbbVie
Phase 3
1,328
Nice, Bordeaux, Reims, Nantes, Lyon, Antony
2023-06-21
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
120
Antibes, Nice
2023-06-14
Active, closed
RHEACELL GmbH & Co. KG
Phase 3
91
Nice, Paris
2023-06-13
Active, closed
AbbVie
Observational
1,019
Nice, Marseille, Besançon, Brest, Quimper, Nîmes, Pessac, Colmar
2023-06-09
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
11
Nice
2023-06-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 1/2
64
Amiens, Bobigny, Caen, Créteil, Lyon, Marseille, Nice, Paris
2023-05-17
Recruiting
Pfizer
Phase 2
100
Nice, Strasbourg, Bordeaux, Toulouse, Vandœuvre-lès-Nancy, Lille, Paris, Lyon
2023-05-17
Recruiting
Fondation Lenval
Not applicable
50
Nice
2023-04-26
Recruiting
Eli Lilly and Company
Phase 1/2
880
Bordeaux, Lyon, Marseille, Nice, Toulouse, Villejuif
2023-04-17
Recruiting
Diagnostic Value of eVOG
NCT05776511Multiple Sclerosis, Radiologically Isolated Syndrome, White Matter Lesions
Centre Hospitalier Universitaire de Nice
Not applicable
150
Nice
2023-04-07
Active, closed
University Hospital, Strasbourg, France
Not applicable
200
Lyon, Nantes, Nice, Reims, Strasbourg, Marseille, Rennes, Saint-Herblain
2023-04-04
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
30
Nice
2023-04-03
Active, closed
Bial R&D Investments, S.A.
Phase 2
237
Nantes, Nice, Nîmes, Paris, Rennes, Toulouse
2023-03-31
Active, closed
Novartis Pharmaceuticals
Phase 4
240
Chambray-lès-Tours, Le Mans, Nice, Paris
2023-03-28
Recruiting
University Hospital, Brest
Not applicable
550
Amiens, Brest, Caen, Créteil, Nantes, Nice, Paris, Tours
2023-03-28
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
200
Bordeaux, Lille, Lyon, Nice, Paris, Poitiers, Rennes, Saint-Priest-en-Jarez
2023-03-22
Recruiting
United Pharmaceuticals
Not applicable
346
Castelnau-le-Lez, Étampes, Libourne, Maromme, Nice, Vincennes
2023-03-17
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
177
Lille, Marseille, Nantes, Nice, Rennes, Toulouse
2023-03-10
Active, closed
Merck Sharp & Dohme LLC
Phase 3
537
Nice, Tourcoing, Paris, Bobigny
2023-03-08
Recruiting
Eli Lilly and Company
Phase 3
595
Brest, Marseille, Nantes, Nice, Paris, Tours
2023-02-27
Active, closed
AstraZeneca
Observational
551
Nice, Clermont-Ferrand, Strasbourg, Finist Re, Dijon, Bordeaux, Grenoble, Saint-Denis
2023-02-27
Active, closed
DBV Technologies
Phase 3
600
Angers, Brest, Bron, Nice, Strasbourg, Vandœuvre-lès-Nancy
2023-02-21
Active, closed
Centre Hospitalier Universitaire de Nice
Not applicable
500
Cannes, Nice
2023-02-16
Active, closed
Development and Test of a Headset for BCI Until Obtaining an Efficient and Comfortable System That Can be Used in Daily Practice by ALS People
NCT04380649Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Spinal Cord Diseases, Alternative Communication Devices
Centre Hospitalier Universitaire de Nice
Not applicable
5
Nice
2023-02-13
Active, closed
Kite, A Gilead Company
Phase 3
300
Bordeaux, Cedex Lyon 08, Dijon, Lille, Montpellier, Nice, Paris, Rennes
2023-02-10
Active, closed
Genmab
Phase 3
900
Nice, Clermont, Marseille, Rennes, Dijon, Limoges, Montpellier, La Tronche
2023-02-08
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
60
Nice, Montpellier, Lille
2023-01-31
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
94
Nice
2023-01-30
Active, closed
argenx
Phase 2
51
Bordeaux, Lille, Nice, Paris
2023-01-18
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Nice, Reims, Marseille, Caen, Dijon, Besançon, Pessac, Toulouse
2023-01-16
Recruiting
Centre Francois Baclesse
Not applicable
504
Bordeaux, Brest, Caen, Grenoble, Le Havre, Lorient, Nice, Paris
2023-01-12
Active, closed
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers
NCT05527184Endometrial Cancer, High Grade Serous Adenocarcinoma of Ovary, Primary Peritoneal Carcinoma, Fallopian Tube Cancer
DrugIMGN151
AbbVie
Phase 1
256
Saint-Herblain, Nice, Lyon, Pierre-Bénite, Villejuif
2023-01-11
Active, closed
Centre Leon Berard
Phase 2
57
Lyon, Nice, Paris, Strasbourg, Toulouse
2023-01-06
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
500
Nice
2023-01-01
Active, closed
Novartis Pharmaceuticals
Phase 3
90
Créteil, Lille, Nantes, Nice
2022-12-30
Recruiting
Centre Hospitalier Universitaire de Nice
Not applicable
15
Nice
2022-12-20
Rows per page Showing 1–500 of 768
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 October 2026. https://priyalifescience.com/clinical-trials-france/city/nice

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 768 of those studies with a site in Nice.

How many clinical trials are recruiting in Nice?

411 of the 768 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 60 have not yet opened recruitment, 286 are active but closed to new participants, and 11 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nice), 768 studies
PhaseStudiesRecruitingShare
Phase 325710833.5%
Not applicable19612425.5%
Observational1237416%
Phase 21146214.8%
Phase 1/231194%
Phase 2/31792.2%
Phase 11592%
Phase 41562%

Most active sponsors

Lead sponsors with the most studies (Nice)
Lead sponsorStudiesRecruiting
Centre Hospitalier Universitaire de Nice194118
AbbVie3210
Merck Sharp & Dohme LLC2110
Novartis Pharmaceuticals203
AstraZeneca196
Centre Antoine Lacassagne1913
Bristol-Myers Squibb1710
Hoffmann-La Roche155
Eli Lilly and Company139
Janssen Research & Development, LLC134
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.